JPH08229026A - Decompression blood-collecting tube - Google Patents

Decompression blood-collecting tube

Info

Publication number
JPH08229026A
JPH08229026A JP7037357A JP3735795A JPH08229026A JP H08229026 A JPH08229026 A JP H08229026A JP 7037357 A JP7037357 A JP 7037357A JP 3735795 A JP3735795 A JP 3735795A JP H08229026 A JPH08229026 A JP H08229026A
Authority
JP
Japan
Prior art keywords
blood
blood collection
collection tube
diatomaceous earth
silicone oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7037357A
Other languages
Japanese (ja)
Other versions
JP2663898B2 (en
Inventor
Tsuyoshi Mashita
剛志 真下
Tsuguo Fujii
嗣雄 藤井
Kazunori Murakami
一徳 村上
Yukinori Enohara
行範 榎原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissho Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissho Corp filed Critical Nissho Corp
Priority to JP7037357A priority Critical patent/JP2663898B2/en
Publication of JPH08229026A publication Critical patent/JPH08229026A/en
Application granted granted Critical
Publication of JP2663898B2 publication Critical patent/JP2663898B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE: To stabilize the coagulation activity of an inorganic material having blood coagulation activity for a long period and exert the coagulation activity of the inorganic material to the maximum extent by coating the inner face of a bottomed tube body made of a synthetic resin with a mixture of PVP and a water-soluble silicone oil, and granularly sticking the diatomaceous earth on the coating face. CONSTITUTION: The space formed with a bottomed tube body, which is made of a synthetic resin, closed at one end, and opened at the other end, and a sealing member, which closes the opened end and can be pierced, is kept at the decompressed state as a decompression blood-collecting tube. The inner face of the bottom tube made of a synthetic resin is coated with a mixture of polyvinyl pyrrolidone and a water-soluble silicone oil, and the diatomaceous earth is granularly stuck on the coating face. The wt.% of the mixture is set to silicone oil: 0.05-0.5 against polyvinyl pyrrolidone: 1. The diatomaceous earth quickly starts dispersion, contact, and coagulation when it is brought into contact with blood, and a high coagulating speed can be realized with a small amount of a coagulant.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は減圧採血管に関するもの
である。減圧採血管は生化学検査・血清学検査・血液学
検査・血糖測定・血液凝固検査・血沈検査・細菌学検査
等に用いられ、開口部を有する有底管にゴム栓を付けた
ものからなる。減圧採血管の使用前には上記有底管の内
部は減圧状態にされている。その減圧度合いは必要なだ
けの血液量(2〜20ミリリットル)を採血できるよう
に適当な減圧状態に保持されている。採血管内では血液
を凝固させ、分離した血清を検査に供する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a reduced-pressure blood collection tube. Decompression blood collection tubes are used for biochemical tests, serological tests, hematological tests, blood glucose measurements, blood coagulation tests, blood sediment tests, bacteriological tests, etc., and consist of a bottomed tube with an opening and a rubber stopper attached. . Before using the reduced pressure blood collection tube, the inside of the bottomed tube is in a reduced pressure state. The degree of pressure reduction is maintained at an appropriate reduced pressure so that a necessary amount of blood (2 to 20 ml) can be collected. Blood is allowed to coagulate in the blood collection tube, and the separated serum is subjected to a test.

【0002】[0002]

【従来の技術】従来から上記有底管の素材はガラスであ
る。しかしガラスは取扱中ことに高速遠心分離操作にお
いて破損しやいため、最近ではこれがポリエステル・ポ
リエチレン・ポリプロピレン等の合成樹脂に代替されつ
つある。ポリエステルとしては、ポリエチレンテレフタ
レートが汎用され、ポリエチレンテレフタレートとの共
重合物も用いられる。
2. Description of the Related Art Conventionally, the material of the bottomed tube is glass. However, glass is liable to break during high-speed centrifugation during handling, and is recently being replaced by synthetic resins such as polyester, polyethylene, and polypropylene. As the polyester, polyethylene terephthalate is generally used, and a copolymer with polyethylene terephthalate is also used.

【0003】ポリエチレンテレフタレートに代表される
合成樹脂製減圧採血管はガラス製減圧採血管よりも管内
で血液を凝固させるとき時間がかかり、実用面で劣って
いた。これを解決するため血液凝固能のある無機物を採
血管内面に付着させることが実行されたが、凝固した血
液が採血管内面に付着し、血清分離が不可能となる。こ
の解決策として、ガラス製減圧採血管で同じ目的に使用
されているシリコーン系の物質を合成樹脂製採血管内面
にコーティングすることが採用されている。
A synthetic resin vacuum blood collection tube typified by polyethylene terephthalate is inferior to a glass vacuum blood collection tube in that it takes more time to coagulate blood in the tube and is inferior in practical use. In order to solve this problem, an inorganic substance having a blood coagulation ability was attached to the inner surface of the blood collection tube, but the coagulated blood attaches to the inner surface of the blood collection tube, and serum separation becomes impossible. As a solution to this problem, a silicone-based material used for the same purpose in a vacuum blood collection tube made of glass is coated on the inner surface of a synthetic resin blood collection tube.

【0004】例えば特公昭59−6655業公報には、
合成樹脂製採血管の内面に血清成分を付着しにくい物質
(シリコーンオイル等)と血清凝固を促進する物質(シ
リカ等の無機物)との分散混合物を付着させた血清分離
用採血管が記載されている。
For example, Japanese Patent Publication No. Sho 59-6655 describes that
A blood collection tube for serum separation is described in which a dispersion mixture of a substance (silicone oil, etc.) that does not easily adhere to serum components and a substance that promotes serum coagulation (inorganic substance such as silica) is adhered to the inner surface of a synthetic resin blood collection tube. There is.

【0005】更に米国特許4,153,739号によれ
ば、通常の減圧採血管の中に存在させているシリコーン
ゲルが、経時とともに採血管の内壁に存在させた無機物
の表面を覆い、その状態下で採血されると血液が採血管
内面の無機物と接触することを妨げられ、採血管内の無
機物の血液凝固活性が経時的に低下すること、このため
血液凝固活性低下を防止する方法として、ポリビニルピ
ロリドン(以下、PVPという。)のアルコール溶液中
に無機物を分散させたものを、採血管内面に付着・乾燥
させることが記載されている。この方法では、血液が管
内面に接すると、PVPが溶解し、無機物は血液中に分
散され、無機物と血液との接触が行われ、血液が凝固す
る。
Further, according to US Pat. No. 4,153,739, the silicone gel present in a normal vacuum blood collection tube covers the surface of the inorganic substance present on the inner wall of the blood collection tube over time. When blood is collected underneath, the blood is prevented from coming into contact with the inorganic substance on the inner surface of the blood collection tube, and the blood coagulation activity of the inorganic material in the blood collection tube decreases with time. It describes that an inorganic substance dispersed in an alcohol solution of pyrrolidone (hereinafter, referred to as PVP) is adhered and dried on the inner surface of a blood collection tube. In this method, when blood comes into contact with the inner surface of the tube, PVP is dissolved, the inorganic substance is dispersed in the blood, the inorganic substance comes into contact with the blood, and the blood coagulates.

【0006】このように従来技術では合成樹脂製減圧採
血管の血清分離性能を向上させるために血液凝固能を有
する無機物、血液付着防止のためのシリコーンオイル、
及びこのシリコーンオイルの無機物表面への付着に起因
する血液凝固性能の経時的低下を防止するためのPVP
の混合物を採血管内面に付着させる方法が採用されてい
る。
As described above, in the prior art, an inorganic substance having a blood coagulation ability for improving serum separation performance of a synthetic resin vacuum blood collection tube, a silicone oil for preventing blood adhesion,
And PVP for preventing a time-dependent decrease in blood coagulation performance caused by adhesion of the silicone oil to the surface of an inorganic substance
Is applied to the inner surface of the blood collection tube.

【0007】然るに従来技術では採血時PVPが血液に
溶解する時間が必要であり、更に無機物表面にはシリコ
ーンオイルも共存しているため、採血管の貯蔵中でも経
時の影響を受けることなく血液凝固性能をいつまでも維
持させることを狙って、無機物の量を増加させたり、凝
固活性点となる表面積の増加を狙って無機物を微小粒径
にする必要があり、工業的に満足された減圧採血管を得
にくかった。
In the prior art, however, it takes time for PVP to dissolve in blood during blood collection, and since silicone oil also coexists on the surface of the inorganic substance, blood coagulation performance is not affected by the passage of time even during storage of the blood collection tube. It is necessary to increase the amount of the inorganic substance in order to maintain it for a long time and to make the inorganic substance into a fine particle diameter in order to increase the surface area that becomes the coagulation active point, and to obtain an industrially satisfactory decompressed blood collection tube. It was difficult.

【0008】[0008]

【発明が解決しようとする課題】本発明の目的は、従来
技術の欠点を解決し、血液凝固活性を示す無機物の凝固
活性が経時に対して長期間安定であること、無機物の凝
固活性を最大限に発揮させることを狙った合成樹脂製減
圧採血管を提供することである。
SUMMARY OF THE INVENTION An object of the present invention is to solve the drawbacks of the prior art, and to ensure that the coagulation activity of an inorganic substance showing blood coagulation activity is stable for a long period of time, and that the coagulation activity of the inorganic substance is maximized. Another object of the present invention is to provide a synthetic resin vacuum blood collection tube aiming to maximize its performance.

【0009】[0009]

【課題を解決するための手段】本発明は、一端が閉塞し
かつ他端が開口した合成樹脂製有底管体と、該開口端を
密閉した穿刺可能な封止部材とを備え、両部材により形
成される空間を減圧状態に保ってなる減圧採血管におい
て、該合成樹脂製有底管体の内面を、PVPと水溶性シ
リコーンオイルとの混合物でコーティングをなし、その
コーティング面上に、珪藻土を粒状で付着させることを
特徴とする減圧採血管を要旨とする。
SUMMARY OF THE INVENTION The present invention comprises a synthetic resin bottomed tube closed at one end and open at the other end, and a pierceable sealing member sealing the open end. In a reduced-pressure blood collection tube in which the space formed by the above is kept under reduced pressure, the inner surface of the synthetic resin bottomed tube is coated with a mixture of PVP and water-soluble silicone oil, and diatomaceous earth is coated on the coated surface. The present invention provides a reduced-pressure blood collection tube, which is characterized in that it is attached in a granular form.

【0010】本発明において封止部材とは減圧採血管に
用いられるものを言う。例えば、脱着可能な弾性を有す
るゴム栓やガスバリヤー部材とシール部材からなる封止
部材を言う。
In the present invention, the term "sealing member" refers to a member used for a reduced-pressure blood collection tube. For example, the term refers to a removable rubber plug or a sealing member including a gas barrier member and a sealing member.

【0011】本発明において有底管体とは減圧採血管と
して用いられるものである。例えば、管外径が10〜1
6ミリメートルφ、管長が60〜170ミリメートルの
ものである。
In the present invention, the bottomed tube is used as a reduced-pressure blood collection tube. For example, when the pipe outer diameter is 10 to 1
It has a diameter of 6 mm and a pipe length of 60 to 170 mm.

【0012】本発明において合成樹脂とはポリエステル
・ポリエチレン・ポリプロピレン等の熱可塑性プラスチ
ックである。この合成樹脂は、酸化防止剤・紫外線遮断
剤・押出用助剤・その重合体改善用添加剤などを含有し
ていてもよい。
In the present invention, the synthetic resin is a thermoplastic such as polyester, polyethylene and polypropylene. The synthetic resin may contain an antioxidant, an ultraviolet ray blocking agent, an extrusion aid, an additive for improving the polymer thereof, and the like.

【0013】採血管には合成樹脂のなかでガスバリヤー
性の優れた高分子が選ばれ、ポリエステル、すなわち、
エチレングリコールとテレフタル酸又はそのエステル
(特にジメチルテレフタレート) との反応によって得ら
れるポリエチレンテレフタレートの使用が推奨できる。
For the blood collection tube, a polymer having excellent gas barrier properties is selected from synthetic resins, and polyester, ie,
Ethylene glycol and terephthalic acid or its ester
The use of polyethylene terephthalate obtained by reaction with (especially dimethyl terephthalate) is recommended.

【0014】上記ポリエステルの重合体の分子量は固有
粘度〔η〕にして0.6〜0.9であれば、成形におい
て問題なく、満足できる有底管体が得られる。この場合
の固有粘度は、フエノール3重量部と1,1,2,2−
テトラクロロエタン2重量部との混合物100ミリリッ
トル中に重合体を0.25グラム溶解してなる溶液にし
て、25℃において測定された値である。
When the molecular weight of the polyester polymer is 0.6 to 0.9 in terms of intrinsic viscosity [η], satisfactory bottomed tubular bodies can be obtained without any problem in molding. In this case, the intrinsic viscosity is 3 parts by weight of phenol and 1,1,2,2-
It is a value measured at 25 ° C. as a solution prepared by dissolving 0.25 g of a polymer in 100 ml of a mixture with 2 parts by weight of tetrachloroethane.

【0015】本発明に用いるPVPは、被膜形成能に優
れ、化粧品等で使用されており、血液を付着させにくい
が、シリコーンオイル等に比べると、やや血液を付着さ
せ易い性質を持っている。しかしPVPは珪藻土の血液
凝固性能そのものを損なうことはなく、血液付着防止に
用いられているシリコーンオイルとの共存下で珪藻土と
の接触表面を優先的に覆い、シリコーンオイルが珪藻土
表面へ付着することを排除する性質を有する。珪藻土の
血液凝固性能を最大に発揮させながら、採血管内面への
血液付着を完全に防止するためには、PVPに少量の水
溶性シリコーンオイルを加え、その混合液を均一に採血
管壁面にコーティングするのが好ましい。
The PVP used in the present invention has excellent film-forming ability and is used in cosmetics and the like, and hardly adheres blood. However, PVP has a property that blood is more easily adhered than silicone oil or the like. However, PVP does not impair the blood coagulation performance of diatomaceous earth itself, and preferentially covers the contact surface with diatomaceous earth in the presence of silicone oil used to prevent blood adhesion, and the silicone oil adheres to the diatomite surface. Has the property of eliminating. In order to completely prevent blood adhesion to the inner surface of the blood collection tube while maximizing the blood coagulation performance of diatomaceous earth, a small amount of water-soluble silicone oil is added to PVP and the mixture is uniformly coated on the wall surface of the blood collection tube. Preferably.

【0016】本発明に用いる珪藻土は、不純物を含まな
いもので、かつ、1000〜1200℃の高温で焼成し
灼熱減量分が除去されたものがよい。そのためにはセラ
イト(セライト社の登録商標)が最も好ましい。
The diatomaceous earth used in the present invention preferably does not contain impurities, and is baked at a high temperature of 1000 to 1200 ° C. to remove the burning loss. For that purpose, Celite (registered trademark of Celite) is most preferable.

【0017】更に血液に接したときに、(PVP+水溶
性シリコーンオイル)の混合物層面が溶解し、コーティ
ング面上の珪藻土を血液中に分散せしめ速やかに血液を
凝固させるには、水溶性シリコーンオイルが好適であ
り、該混合物のコーティング層は薄いほどよい。珪藻土
の血液凝固性能を最大限利用するには採血管壁面上の珪
藻土がPVPやシリコーンオイルに覆われてない自然の
ままで存在するのが好ましい。しかし自然のまま壁面に
付着することは不可能であり、水やアルコールのバイン
ダーが必要となる。バインダーは珪藻土の凝固性能や採
血管壁面の血液付着防止能に影響しないものが好まし
い。
Further, when the mixture layer of (PVP + water-soluble silicone oil) is dissolved in blood and the diatomaceous earth on the coating surface is dispersed in the blood and the blood is quickly coagulated, the water-soluble silicone oil is used. Preferably, the thinner the coating layer of the mixture, the better. In order to maximize the blood coagulation performance of diatomaceous earth, it is preferable that the diatomaceous earth on the blood collection tube wall be present as it is without being covered with PVP or silicone oil. However, it is impossible to adhere to the wall surface as it is, and a binder of water or alcohol is required. It is preferable that the binder does not affect the coagulation performance of the diatomaceous earth or the blood adhesion prevention ability on the wall of the blood collection tube.

【0018】珪藻土を自然に近い状態で存在させるとは
採血管内面の血液付着防止用混合物層上に珪藻土を載せ
る状態で存在させることであり、そのためには(PVP
+水溶性シリコーンオイル)の混合物層が珪藻土の粒子
形状に比較して薄く、珪藻土を該混合物層表面に強く吹
きつけても珪藻土が該混合物層内に埋没しないことが重
要であり、珪藻土の平均粒径は該混合物層厚さの10倍
以上、好ましくは30倍以上が必要である。しかも該混
合物層上に珪藻土が付着できるようなバインダーを珪藻
土と共に吹きつけることが重要である。
The existence of diatomaceous earth in a state close to nature means that diatomaceous earth is present in a state where diatomaceous earth is placed on a blood adhesion preventing mixture layer on the inner surface of a blood collection tube.
It is important that the mixture layer of (+ water-soluble silicone oil) is thinner than the particle shape of the diatomaceous earth, and that even if the diatomaceous earth is strongly blown to the surface of the mixture layer, the diatomaceous earth is not buried in the mixture layer. The particle size must be 10 times or more, preferably 30 times or more the thickness of the mixture layer. In addition, it is important to spray a binder together with the diatomaceous earth so that the diatomaceous earth can adhere to the mixture layer.

【0019】本発明では採血管内面に少量の水溶性シリ
コーンオイルを含んだPVPをコーティングしてあるの
で、水又はイソプロピルアルコールに珪藻土を分散した
分散物を採血管内面の混合物層上に吹きつけると混合物
層面のPVPとシリコーンオイルがバインダーの性質も
示し、珪藻土を採血管内面に好適に付着させる。従って
(PVP+水溶性シリコーンオイル)の混合物層の厚さ
は珪藻土吹きつけ時の水やアルコールによりバインダー
になりうるだけの厚さが必要となるが、できるだけ薄い
ことが重要である。
In the present invention, the inner surface of the blood collection tube is coated with PVP containing a small amount of water-soluble silicone oil. Therefore, when a dispersion of diatomaceous earth in water or isopropyl alcohol is sprayed onto the mixture layer on the inner surface of the blood collection tube. The PVP and silicone oil on the surface of the mixture layer also show the property of a binder, and the diatomaceous earth is suitably attached to the inner surface of the blood collection tube. Accordingly, the thickness of the mixture layer of (PVP + water-soluble silicone oil) needs to be as thick as possible as a binder with water or alcohol when spraying diatomaceous earth, but it is important that it is as thin as possible.

【0020】本発明の合成樹脂製減圧採血管は管内面に
少量の水溶性シリコーンオイルを混合したPVPの薄い
層を形成させ、珪藻土をその平均粒径が該混合物層の厚
さの少なくとも10倍以上で該混合物層上に存在させた
ものであり、採血管内面に該混合物層で覆われてない珪
藻土が存在し、その結果優れた血液凝固性能を示すもの
である。このような構成であるので、本発明の採血管は
長期間貯蔵されてもその血液凝固性能が劣化することが
なく、具体的には採血管製造後約8ヵ月〜1年間の貯蔵
後、血液検査に供しても血液凝固時間が9分以内とな
る。また本発明の構成が優れているため採血管内の珪藻
土の使用量が少なくてすむ。その結果、本発明によれば
外観のよい採血管を提供できる。
The synthetic resin vacuum blood collection tube of the present invention has a thin layer of PVP mixed with a small amount of water-soluble silicone oil formed on the inner surface of the tube, and the diatomaceous earth has an average particle size at least 10 times the thickness of the mixture layer. As described above, the diatomaceous earth not covered with the mixture layer is present on the inner surface of the blood collection tube, and as a result, excellent blood coagulation performance is exhibited. Due to such a constitution, the blood collection tube of the present invention does not deteriorate in blood coagulation performance even if it is stored for a long period of time. Specifically, after the blood collection tube is stored for about 8 months to 1 year, The blood coagulation time is less than 9 minutes even after the test. Further, since the configuration of the present invention is excellent, the amount of diatomaceous earth used in the blood collection tube can be reduced. As a result, according to the present invention, a blood collection tube having a good appearance can be provided.

【0021】PVPと水溶性シリコーンオイルの混合比
は血液付着性能及び凝固時間と関係する。重量比でPV
Pを1に対して水溶性シリコーンオイルを0.05未満
にすると管壁に血液が付着して採血管外部から血液の凝
固状態を観察することが難しく、これが0.5を超える
と水溶性シリコーンオイルが珪藻土表面に付着し、採血
管貯蔵中に変化をもたらし、血液凝固に時間がかかる採
血管になってしまう。従ってこの重量比は0.05〜
0.5の範囲であり、好ましくは0.1〜0.3の範囲
である。
The mixing ratio of PVP and water-soluble silicone oil is related to blood adhesion performance and coagulation time. PV by weight
If P is less than 0.05 and the water-soluble silicone oil is less than 0.05, blood adheres to the tube wall and it is difficult to observe the coagulation state of the blood from outside the blood collection tube. The oil adheres to the surface of the diatomaceous earth, causing changes during storage of the blood collection tube, resulting in a blood collection tube that takes a long time to coagulate. Therefore, this weight ratio is 0.05 to
It is in the range of 0.5, preferably in the range of 0.1 to 0.3.

【0022】次に重量比で珪藻土を1に対して、(PV
P+水溶性シリコーンオイル)の混合物を0.2〜1.
0とすることを説明する。有効血液接触面積が約39平
方センチメートルであり10cc採血用であるポリエス
テル製採血管の血液接触部にPVPと水溶性シリコーン
オイル(表1でCOと示す)の混合物をイソプロピルア
ルコールに溶解してスプレーを用いて均一に散布し、5
0℃の熱風で乾燥した。混合比、スプレー量を調節し
て、PVPに対する水溶性シリコーンオイルの量を4基
準にした4種の採血管を作成した。この採血管内面に血
液凝固剤であるセライトSuper Floss(セラ
イト社製焼成珪藻土)をイソプロピルアルコールに分散
させ、次いでこれをスプレーで均一に散布し、セライト
量に差を付けて8種類の採血管を表1の通り作成した。
Next, the weight ratio of diatomaceous earth to 1: (PV
P + water-soluble silicone oil) in the range of 0.2 to 1.
The setting of 0 will be described. A mixture of PVP and water-soluble silicone oil (indicated as CO in Table 1) was dissolved in isopropyl alcohol and sprayed on the blood contact part of a polyester blood collection tube having an effective blood contact area of about 39 cm 2 and 10 cc for blood collection. And evenly spread 5
It was dried with hot air at 0 ° C. By adjusting the mixing ratio and the spray amount, four types of blood collection tubes were prepared on the basis of the amount of the water-soluble silicone oil with respect to PVP. Celite Super Floss (fired diatomaceous earth manufactured by Celite), which is a blood coagulant, is dispersed in isopropyl alcohol on the inner surface of the blood collection tube, and then this is uniformly sprayed with a spray. It was created as shown in Table 1.

【0023】[0023]

【表1】 [Table 1]

【0024】表1の採血管を用いて、採血管貯蔵中の血
液凝固性能の変化状況を調べた。但し、この変化を加速
させて50℃で4週間までのシミュレーションを行い、
10人の健常人からの血液の凝固時間を平均して調べ
た。
Using the blood collection tubes shown in Table 1, changes in blood coagulation performance during storage of the blood collection tubes were examined. However, by accelerating this change and performing a simulation at 50 ° C for up to 4 weeks,
The blood coagulation times from 10 healthy persons were investigated on average.

【0025】本発明は採血管を常温で8カ月貯蔵した後
でも、その血液凝固時間が9分以内であることを目標に
している。常温で8カ月貯蔵は本発明のシミュレーショ
ンでは50℃で4週間の貯蔵に相当すると考えられてい
る。凝固性判定の規準は凝固時間が9分以内を○、9〜
9.5分を△、10分以上を×で示した。また採血管内
面にセライト・シリコーンオイル・PVPの混合物を散
布し、セライトの表面がPVPで覆われたものをブラン
クとして対比した。
The present invention aims at keeping the blood coagulation time within 9 minutes even after storing the blood collection tube at room temperature for 8 months. Storage at room temperature for 8 months is considered to correspond to storage at 50 ° C. for 4 weeks in the simulation of the present invention. The criterion for determining the coagulability is that the coagulation time is 9 minutes or less,
9.5 minutes are indicated by Δ, and 10 minutes or more are indicated by ×. Further, a mixture of Celite / silicone oil / PVP was sprayed on the inner surface of the blood collection tube, and the one in which the surface of Celite was covered with PVP was compared as a blank.

【0026】セライトに対するPVP・水溶性シリコー
ンオイル(表2でCOと示す)の混合物層の比と血液凝
固性の関係を表2に示す。
Table 2 shows the relationship between the ratio of the mixture layer of PVP and water-soluble silicone oil (shown as CO in Table 2) to celite and the blood coagulability.

【0027】[0027]

【表2】 [Table 2]

【0028】表2から明かなように珪藻土に対する(P
VP+水溶性シリコーンオイル)の混合物の比が1を超
えると凝固時間が長くなり、ブランクと変わらなくな
る。この値が0.2より小となると珪藻土の量が多くな
り、採血管内壁に均一な面が得られなくなり、減圧採血
管の商品価値を損なうものとなる。このことより珪藻土
に対する(PVP+水溶性シリコーンオイル)の混合物
の重量比は珪藻土の1に対して該混合物の0.2〜1.
0の範囲が適当である。
As is apparent from Table 2, (P
If the ratio of the mixture of VP + water-soluble silicone oil) exceeds 1, the coagulation time becomes long and is the same as the blank. If this value is smaller than 0.2, the amount of diatomaceous earth increases, and a uniform surface cannot be obtained on the inner wall of the blood collection tube, which impairs the commercial value of the reduced-pressure blood collection tube. From this, the weight ratio of the mixture of (PVP + water-soluble silicone oil) to diatomaceous earth was 0.2-1.
A range of 0 is appropriate.

【0029】次に減圧採血管内面に形成する「(PVP
+水溶性シリコーンオイル)の混合物のコーティング厚
さ」と「珪藻土の平均粒径」との関係について説明す
る。珪藻土粒径とは、珪藻土をコーティング層に付着さ
せた状態で、コーティング面に接した部分を底辺とした
ときの珪藻土最大頂点と底辺との距離であり、平均粒径
とは使用した珪藻土粒子径の平均である。
Next, “(PVP) is formed on the inner surface of the reduced-pressure blood collection tube.
The coating thickness of the mixture of water-soluble silicone oil) and the average particle diameter of diatomaceous earth will be described. Diatomaceous earth particle size is the distance between the diatomaceous earth maximum apex and the bottom when the portion in contact with the coating surface is the bottom, with diatomaceous earth adhered to the coating layer, and the average particle size is the diameter of the diatomite particle used Is the average of

【0030】イソプロパノールにPVPの1重量%と水
溶性シリコーンオイルの0.2重量%を溶解した混合液
を10cc採血用のポリエステル製減圧採血管の内面に
スプレーを用いて種々の度合いで均一に散布後、50℃
の熱風で乾燥し平均厚さ約0.03、0.05、0.
1、0.2、0.4、0.6、0.8、1.0μmの混
合物層を形成させた。イソプロピルアルコールに平均粒
径約1、2、3、5、6、8、10、12μmのセライ
トSuper Flossをそれぞれ1重量%加え、ホ
モゲナイザーで十分に混合した分散液をスプレーで、前
記採血管内面の混合物層上に散布し、50℃の熱風で乾
燥し珪藻土付着量が約0.015mg/平方センチメー
トルとなることを目標にした。使用した10cc採血用
採血管の有効血液接触面積は、39平方センチメートル
なので、血液凝固に関与する珪藻土量はほぼ0.60m
gとなる。
A mixture of 1% by weight of PVP and 0.2% by weight of water-soluble silicone oil in isopropanol was sprayed evenly to various extents on the inner surface of a 10 cc polyester vacuum blood collection tube using a spray. After that, 50 ℃
And dried with hot air of an average thickness of about 0.03, 0.05, 0.
A mixture layer of 1, 0.2, 0.4, 0.6, 0.8, 1.0 μm was formed. 1% by weight of Celite Super Floss having an average particle size of about 1, 2, 3, 5, 6, 8, 10, and 12 μm was added to isopropyl alcohol, and a dispersion sufficiently mixed with a homogenizer was sprayed onto the inner surface of the blood collection tube. It was sprayed on the mixture layer, dried with hot air at 50 ° C., and aimed at a diatomaceous earth adhesion amount of about 0.015 mg / cm 2. The effective blood contact area of the 10 cc blood collection tube used was 39 square centimeters, so the amount of diatomaceous earth involved in blood coagulation was approximately 0.60 m.
It becomes g.

【0031】製作直後、採血管内面の珪藻土付着状況を
5000倍に拡大した顕微鏡で観察した。なお、珪藻土
の付着量については採血量1cc当り0.02〜0.1
0mgあれば十分であり、過剰な珪藻土は凝固時間を短
縮するが、溶血を起こすので、珪藻土の使用量決定には
過剰を避けることが重要である。コーティング層厚さと
珪藻土粒径とが珪藻土粒子付着状況に及ぼす効果の観察
結果を表3に示す。
Immediately after fabrication, the state of adhesion of diatomaceous earth to the inner surface of the blood collection tube was observed with a microscope magnified 5000 times. The amount of diatomaceous earth attached was 0.02-0.1 per 1 cc of blood collected.
0 mg is sufficient, and excessive diatomaceous earth shortens the coagulation time, but causes hemolysis, so it is important to avoid excess in determining the amount of diatomaceous earth used. Table 3 shows the observation results of the effects of the coating layer thickness and the diatomaceous earth particle size on the diatomaceous earth particle adhesion status.

【0032】[0032]

【表3】 [Table 3]

【0033】付着状況判定規準 I:珪藻土粒子表面をコーティング層が部分的に覆い、
凝固活性が不足 II:珪藻土粒子表面をコーティング層上に露出してお
り、凝固活性は良好 III:珪藻土粒子がコーティング層に保持されていない
ものが存在する。珪藻土粒子をコーティング層上に均一
分散不可能。
Criteria for judging adhesion condition I: The coating layer partially covers the surface of the diatomaceous earth particles,
Insufficient coagulation activity II: The surface of the diatomaceous earth particles is exposed on the coating layer, and the coagulation activity is good. III: Some diatomaceous earth particles are not retained in the coating layer. Diatomaceous earth particles cannot be uniformly dispersed on the coating layer.

【0034】表3の結果より珪藻土粒子の平均径は、平
均コーティング層厚さの10倍以上、100倍以下で、
10μm以下が好適であり、コーティング層厚さは0.
05〜1.00μmの範囲が好ましい。
From the results shown in Table 3, the average diameter of the diatomaceous earth particles is 10 times or more and 100 times or less the average coating layer thickness.
The thickness is preferably 10 μm or less, and the thickness of the coating layer is 0.1 μm.
The range of from 0.05 to 1.00 μm is preferred.

【0035】以下、実施例により本発明の効果を更に具
体的に説明する。 〔実施例1〕イソプロパノールにPVPの1重量%、水
溶性シリコーンオイルの0.1、0.2、0.3、0.
4、0.5重量%をそれぞれ溶解した混合液と比較例と
して水溶性シリコーンオイルのないものとそれを0.6
重量%溶解した混合液をポリエステル製の有底管体の減
圧採血管(10cc採血用)のそれぞれ内面に、スプレ
ーを用いて均一に散布後、50℃の熱風で乾燥し平均厚
さ約0.1μmの混合物層を形成させた。イソプロパノ
ールに平均粒径約4μmのセライトSuperFlos
sを1重量%加え、ホモゲナイザーで徹底的に混合した
分散液をスプレーを用いて、前記採血管内面の混合物層
上に散布し、50℃の熱風で乾燥し、セライトSupe
r Floss付着量が約0.015mg/平方センチ
メートルの採血管を得た。10cc採血用採血管の有効
血液接触面積は約39平方センチメートルなので、血液
凝固に関与するセライトSuper Floss量は
0.60mgとなる。
Hereinafter, the effects of the present invention will be described more specifically with reference to examples. Example 1 1% by weight of PVP in isopropanol and 0.1, 0.2, 0.3, 0.1% of water-soluble silicone oil.
4 and 0.5% by weight, respectively, as a comparative example.
The mixed solution in which the weight percent was dissolved was sprayed uniformly on the inner surface of a polyester bottomed blood tube (for collecting 10 cc blood) using a spray, dried with hot air at 50 ° C., and dried to an average thickness of about 0.1 mm. A 1 μm mixture layer was formed. Celite SuperFlos having an average particle size of about 4 μm in isopropanol
was added to the mixture layer on the inner surface of the blood collection tube using a spray, sprayed with hot air at 50 ° C., and dried with Celite Supe.
A blood collection tube having an r Floss adhesion amount of about 0.015 mg / cm 2 was obtained. Since the effective blood contact area of the blood collection tube for 10 cc blood collection is about 39 square centimeters, the amount of Celite Super Floss involved in blood coagulation is 0.60 mg.

【0036】上記採血管の製作直後及び、50℃の状態
で上記採血管を1、3、6週間貯蔵後の時点において各
採血管に常法により10cc採血し、血液凝固時間をそ
れぞれ測定した。同時に採血管壁の血液付着状態、採血
管内面のセライトSuperFloss付着状況を50
00倍に拡大した顕微鏡で観察した。表4にその結果を
示す。本実施例で50℃で6週間は常温下約1年間のシ
ミュレーションと考えた。
Immediately after the preparation of the blood collection tube and after storage at 50 ° C. for 1, 3, and 6 weeks, 10 cc of blood was collected from each blood collection tube by a conventional method, and the blood coagulation time was measured. At the same time, the blood adhesion state of the blood collection tube wall and the Celite SuperFloss adhesion state of the blood collection tube inner surface are 50
Observation was performed with a microscope magnified to 00 times. Table 4 shows the result. In this example, it was assumed that 6 weeks at 50 ° C. was a simulation at room temperature for about 1 year.

【0037】[0037]

【表4】 [Table 4]

【0038】珪藻土付着状況はPVPの皮膜形成能のた
め、珪藻土有効面積がやや少なく、血液接触後の管壁コ
ーティング層の溶解に時間がかかる場合を△で示し、こ
の問題のないものを○で示した。水溶性シリコーンオイ
ルを含まない場合、採血後の血液凝固時に採血管壁面に
血液が付着し、凝固状況を確認するのに障害となる。更
にシリコーンオイルの量が増加し、それがPVP量の6
0%になると減圧採血管の貯蔵中に血液凝固性能が低下
する。このように採血管内面の混合物層は水溶性シリコ
ーンオイル/PVPの比が0.1〜0.5の重量比に於
いて好結果をもたらしている。総合判定ではシリコーン
オイルがない場合や0.6重量%の場合は不良であっ
た。
The diatomaceous earth adhesion state is indicated by Δ when the effective area of diatomaceous earth is slightly small due to the ability of PVP to form a film, and it takes time to dissolve the tube wall coating layer after blood contact. Indicated. When the water-soluble silicone oil is not contained, blood adheres to the wall surface of the blood collection tube during blood coagulation after blood collection, which is an obstacle to confirming the coagulation state. Furthermore, the amount of silicone oil increases, which is 6% of the amount of PVP.
At 0%, the blood coagulation performance decreases during storage of the vacuum blood collection tube. Thus, the mixture layer on the inner surface of the blood collection tube gives a good result at a weight ratio of water-soluble silicone oil / PVP of 0.1 to 0.5. The overall judgment was poor when there was no silicone oil or when 0.6% by weight.

【0039】〔実施例2〕イソプロパノールにPVPの
1重量%、水溶性シリコーンオイルの0.1重量%を溶
解した混合液をポリエステル製の有底管体の減圧採血管
(10cc採血用)内面に、スプレーを用いて均一に散
布後、50℃の熱風で乾燥し平均厚さ約0.1μmの混
合物層を形成させた。イソプロピルアルコールに平均粒
径約4μm(最大7μm)のセライトSuper Fl
ossを1重量%加え、ホモゲナイザーで十分に混合し
た分散液をスプレーを用いて、前記採血管内面の混合物
層上に散布し、50℃の熱風で乾燥し、セライトSup
er Floss付着量が約0.30mgの採血管を製
作した。
Example 2 A mixture of 1% by weight of PVP and 0.1% by weight of a water-soluble silicone oil dissolved in isopropanol was applied to the inner surface of a vacuum tube (for collecting 10 cc blood) of a bottomed tube made of polyester. After spraying uniformly using a spray, the mixture was dried with hot air at 50 ° C. to form a mixture layer having an average thickness of about 0.1 μm. Celite Super Fl with an average particle size of about 4 µm (up to 7 µm) in isopropyl alcohol
was added to the mixture layer on the inner surface of the blood collection tube using a spray, sprayed with hot air at 50 ° C., and Celite Sup was added.
A blood collection tube having an er Floss attachment amount of about 0.30 mg was prepared.

【0040】該採血管の製作直後、採血管内面のセライ
トSuper Floss付着状況を5000倍に拡大
した顕微鏡で観察した。珪藻土は混合物上に存在し、混
合物層に接した面の反対側にあたる珪藻土の表面には混
合物層は認められなかった。経時変化を加速させる50
℃で4週間のシミュレーション試験で、血液の凝固時間
は9.0分であり、珪藻土量が少ないために採血管外観
も極めて良好であった。
Immediately after the production of the blood collection tube, the adhesion state of Celite Super Floss on the inner surface of the blood collection tube was observed with a microscope magnified 5000 times. The diatomaceous earth was present on the mixture, and no mixture layer was found on the surface of the diatomaceous earth opposite to the surface in contact with the mixture layer. 50 to accelerate changes over time
In a simulation test at 4 ° C. for 4 weeks, the blood had a coagulation time of 9.0 minutes, and the appearance of the blood collection tube was extremely good due to the small amount of diatomaceous earth.

【0041】[0041]

【発明の効果】以上述べたたように本発明によれば、減
圧採血管内の血液凝固活性を示す珪藻土が血液と接する
と速やかに分散・接触・凝固を開始し、少ない凝固剤で
速い凝固速度を実現し、また、減圧採血管の貯蔵中にお
ける凝固活性低下を防止し、いつまでも良好な外観を保
ちうる減圧採血管が提供される。
As described above, according to the present invention, when diatomaceous earth having blood coagulation activity in a reduced-pressure blood collection tube comes into contact with blood, dispersion / contact / coagulation starts immediately, and a high coagulation rate can be achieved with a small amount of coagulant. And a reduced-pressure blood collection tube capable of preventing a decrease in coagulation activity during storage of the reduced-pressure blood collection tube and maintaining a good appearance forever.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 榎原 行範 大阪市北区本庄西3丁目9番3号 株式会 社ニッショー内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yukinori Enohara 3-9-3 Honjo Nishi, Kita-ku, Osaka City

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 一端が閉塞しかつ他端が開口した合成樹
脂製有底管体と、該開口端を密閉した穿刺可能な封止部
材とを備え、両部材により形成される空間を減圧状態に
保ってなる減圧採血管において、該合成樹脂製有底管体
の内面を、ポリビニルピロリドンと水溶性シリコーンオ
イルとの混合物でコーティングをなし、そのコーティン
グ面上に、珪藻土を粒状で付着させることを特徴とする
減圧採血管。
1. A bottomed tube made of synthetic resin, one end of which is closed and the other end of which is open, and a pierceable sealing member which seals the open end, and a space formed by both members is decompressed. In the reduced-pressure blood collection tube, the inner surface of the synthetic resin bottomed tube is coated with a mixture of polyvinylpyrrolidone and water-soluble silicone oil, and diatomaceous earth is adhered in a granular form on the coated surface. Characterized vacuum blood collection tube.
【請求項2】 ポリビニルピロリドンと水溶性シリコー
ンオイルとの混合物の重量比が、ポリビニルピロリドン
1に対して水溶性シリコーンオイルを0.05〜0.5
にしたことを特徴とする請求項1記載の減圧採血管。
2. The weight ratio of the mixture of polyvinylpyrrolidone and water-soluble silicone oil is such that the ratio of the water-soluble silicone oil to the polyvinylpyrrolidone is 0.05 to 0.5.
The reduced pressure blood collection tube according to claim 1, wherein
【請求項3】 ポリビニルピロリドンと水溶性シリコー
ンオイルとの混合物の厚さの平均が0.05〜1.0μ
mであることを特徴とする請求項1記載の減圧採血管。
3. The average thickness of a mixture of polyvinylpyrrolidone and a water-soluble silicone oil is 0.05 to 1.0 μm.
The reduced pressure blood collection tube according to claim 1, wherein the reduced pressure blood collection tube is m.
【請求項4】 珪藻土の平均粒径が、10μm以下で、
かつ、ポリビニルピロリドンと水溶性シリコーンオイル
との混合物のコーティング層の厚さの10〜100倍で
あることを特徴とする請求項1記載の減圧採血管。
4. The average particle size of diatomaceous earth is 10 μm or less,
The reduced pressure blood collection tube according to claim 1, wherein the thickness is 10 to 100 times the thickness of the coating layer of the mixture of polyvinylpyrrolidone and water-soluble silicone oil.
【請求項5】 重量比で珪藻土を1に対して、ポリビニ
ルピロリドンと水溶性シリコーンオイルとの混合物を
0.2〜1.0とすることを特徴とする請求項1記載の
減圧採血管。
5. The reduced-pressure blood collection tube according to claim 1, wherein the weight ratio of diatomaceous earth to 1, and the mixture of polyvinylpyrrolidone and water-soluble silicone oil are 0.2 to 1.0.
JP7037357A 1995-02-24 1995-02-24 Vacuum blood collection tube Expired - Lifetime JP2663898B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7037357A JP2663898B2 (en) 1995-02-24 1995-02-24 Vacuum blood collection tube

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7037357A JP2663898B2 (en) 1995-02-24 1995-02-24 Vacuum blood collection tube

Publications (2)

Publication Number Publication Date
JPH08229026A true JPH08229026A (en) 1996-09-10
JP2663898B2 JP2663898B2 (en) 1997-10-15

Family

ID=12495298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7037357A Expired - Lifetime JP2663898B2 (en) 1995-02-24 1995-02-24 Vacuum blood collection tube

Country Status (1)

Country Link
JP (1) JP2663898B2 (en)

Also Published As

Publication number Publication date
JP2663898B2 (en) 1997-10-15

Similar Documents

Publication Publication Date Title
US4836217A (en) Hypersensitivity test means
AU692252B2 (en) Biocompatible coated article
Tay et al. Water treeing in simplified dentin adhesives-deja vu?
US5773021A (en) Bioadhesive ophthalmic insert
US4983392A (en) Bioadhesive compositions and methods of treatment therewith
Amiji et al. Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers
US3849185A (en) Method of preparing surgical sutures
US3941858A (en) Hydrophilic polymers, articles and methods of making same
AU705376B2 (en) Blended pressure-sensitive adhesives
US4842597A (en) Hydrophilic copolymers for wound dressings and other biomedical uses
US6632522B1 (en) Blended pressure-sensitive adhesives
US20070160647A1 (en) Materials for medical implants and occlusive devices
CA1145082A (en) Covering material
JP2002526560A (en) Composition comprising a thermoplastic component and a superabsorbent polymer
US20030129403A1 (en) Barrier material with nanosize metal particles
US5549908A (en) Hydrolytically labile microspheres of polysaccharide crosslinked with cyanogen halide and their application in wound dressings
WO1999056782A1 (en) Adhesive microsphere drug delivery composition
NZ267488A (en) Topical psoriasis treatment composition comprising a film-forming agent
US4226915A (en) Pressure-sensitive adhesive tape or sheet
Ribardiere et al. Modification of ketoprofen bead structure produced by the spherical crystallization technique with a two-solvent system
JP2663898B2 (en) Vacuum blood collection tube
Lehr et al. Visualization studies of the mucoadhesive interface
EP3929221A1 (en) Particles for cell adhesion and utilization thereof
JPS63152311A (en) Sustained release preparation for oral cavity
US5169543A (en) Serum separation sealant and fine resin particles using the same

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100620

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110620

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110620

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120620

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140620

Year of fee payment: 17

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term